Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rangering i aksjer #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Aksjekurs
$0.25974701
Sist synkronisert: 2025-01-06
Markedsverdi
$2.04M
Endring (1 dag)
0.74%
Endring (1 år)
0.00%
Land
FR
Handel Acticor Biotech SAS (ALACT)

Kategori

Healthcare
Antall utestående aksjer for Acticor Biotech SAS (ALACT)
Antall utestående aksjer per June 2024: 15.76M
Ifølge Acticor Biotech SAS sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 15.76M. Ved slutten av December 2022 hadde selskapet 10.55M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Acticor Biotech SAS (ALACT) fra 2010 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 15.76M 30.55%
2023 12.07M 14.44%
2022 10.55M 35.54%
2021 7.78M 22.37%
2020 6.36M 21.38%
2019 5.24M 70.67%
2018 3.07M -7.38%
2017 3.31M 0.00%
2016 3.31M 0.00%
2015 3.31M 0.00%
2014 3.31M 0.00%
2013 3.31M 0.71%
2012 3.29M 0.00%
2011 3.29M -34.01%
2010 4.99M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 1,511.53%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 294.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 2,939.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 2,413.45%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH